It is a pharma public limited company based in Punjab, Punjab, India, established in 1996.
1996 | Punjab, Punjab, India | ActiveNayan Pharmaceuticals Limited, a active public limited company, was established on 26 November 1996 in Punjab, Punjab, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231PB1996PLC019085. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹0.91 M.
It upholds a compliant status. Its leadership includes Shiv Shankar Srivastava (Director), Akshay Kumar Srivastava (Director), Manohar Lal Verma (Director). Past directors included Preet Kiran, Tejinder Kaur Bedi. It holds ₹2.30 M open charges and ₹0.90 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Deelwal Morh Distt Patiala, Punjab, Punjab, 147001.
U24231PB1996PLC019085
019085
26 November 1996
₹2.00 M
₹0.91 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Nayan Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shiv Shankar Srivastava | Director | 26 Nov 1996 | Current |
| Akshay Kumar Srivastava | Director | 16 Jul 2016 | Current |
| Manohar Lal Verma | Director | 14 Dec 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 14 Dec 2022 | Past |
| Pramod Abcsdd | Director | 24 Mar 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nayan Pharmaceuticals Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 49.53% increase. The company also saw a substantial improvement in profitability, with a 531.29% increase in profit. The company's net worth moved up by a moderate rise of 6.61%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Nayan Pharmaceuticals had a promoter holding of 96.15% and a public holding of 3.85%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,300,000.00
₹900,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Oct 2023 | Canara Bank | ₹1.60 M | Open |
| 07 Jan 1998 | Canara Bank | ₹0.70 M | Open |
| 13 Aug 2009 | Canara Bank | ₹0.50 M | Satisfied |
| 07 Jan 1998 | Canara Bank | ₹0.40 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Nayan Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Nayan Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nayan Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Nayan Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Nayan Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was documented.
A charge with Canara Bank amounted to Rs. 1.60 M with Charge ID 100835999 was registered on 30 Oct 2023. was recorded as a recent event.
Manohar Lal Verma was appointed as a Director was appointed as a Director on 14 Dec 2022 & has been associated with this company since 2 years 11 months . was recorded as a recent event.
A charge registered on 07 Jan 1998 via Charge ID 90173517 with Canara Bank was fully satisfied on 27 Oct 2022. was recorded as a recent event.
The activity A charge registered on 13 Aug 2009 via Charge ID 10174432 with Canara Bank was fully satisfied on 26 Oct 2022. was completed.
The CIN of Nayan Pharmaceuticals Limited is U24231PB1996PLC019085.
Nayan Pharmaceuticals Limited is headquartered at Deelwal Morh Distt Patiala, Punjab, Punjab, 147001.
Nayan Pharmaceuticals Limited was incorporated on 26 November 1996.
The current directors of Nayan Pharmaceuticals Limited are
The primary industry of Nayan Pharmaceuticals Limited is Manufacturing.
Nayan Pharmaceuticals Limited is unlisted.
The authorized capital of Nayan Pharmaceuticals Limited is ₹2.00 M, and the paid-up capital is ₹0.91 M.
The compliance status of Nayan Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX